Jacqueline Garcia: Evaluating Venetoclax Plus Azacitidine in Patients with High-Risk MDS

preview_player
Показать описание

  1. American Society of Hematology
Рекомендации по теме
Jacqueline Garcia: Evaluating 0:06:53

Jacqueline Garcia: Evaluating Venetoclax Plus Azacitidine in Patients with High-Risk MDS

Dr. Jacqueline Garcia 0:00:58

Dr. Jacqueline Garcia presents results of a trial using venetoclax in stem cell transplants.

Venetoclax plus azacitidine 0:08:54

Venetoclax plus azacitidine in treatment-naïve higher-risk MDS

Venetoclax in combination 0:05:52

Venetoclax in combination with azacitidine for patients with treatment-naïve HR-MDS

Jacqueline Garcia: Evaluating 0:04:21

Jacqueline Garcia: Evaluating Navitoclax for Myelofibrosis

Venetoclax plus azacitidine 0:06:58

Venetoclax plus azacitidine for higher-risk MDS

Phase III VERONA 0:03:07

Phase III VERONA study of venetoclax with azacitidine in treatment-naïve higher-risk MDS

How can cytogenetics 0:03:49

How can cytogenetics predict response to venetoclax and azacitidine in MDS?

Drs. Anthony Letai 0:03:35

Drs. Anthony Letai and Jacqueline Garcia on Dana-Farber’s Momentum of Discovery

Comparison of venetoclax-based 0:07:55

Comparison of venetoclax-based versus non-venetoclax-based treatment regimens in AML

AML Specialists and 0:02:55

AML Specialists and Second Opinions | Expert Advice to Patients

Does the addition 0:10:04

Does the addition of venetoclax to low-dose conditioning improve outcome after allo-HSCT?

Rationale of OMNIVERSE: 0:01:51

Rationale of OMNIVERSE: oral azacitidine + venetoclax in patients with R/R or newly diagnosed AML

How can the 0:19:36

How can the hematologic toxicities with Ven+Aza be managed more effectively?

Acute Myeloid Leukemia 0:02:45

Acute Myeloid Leukemia Care | Who Are the Essential Team Members?

Investigating the combination 0:03:53

Investigating the combination of pivekimab sunirine, azacitidine & venetoclax in R/R AML

Venetoclax and azacitidine 0:01:57

Venetoclax and azacitidine for AML ineligible for standard induction

Result of venetoclax 0:01:56

Result of venetoclax plus/minus azacitidine for R/R MDS

Venetoclax prior to 0:09:46

Venetoclax prior to allo-HCT for high-risk myeloid malignancies

New research in 0:02:18

New research in acute myeloid leukemia

Talking Post-Transplant Acute 0:58:36

Talking Post-Transplant Acute Myeloid Leukemia - Improving Outcomes after Relapse

Venetoclax plus azacitidine 0:03:51

Venetoclax plus azacitidine in treatment-naïve and R/R MDS

Dr. Garcia on 0:01:07

Dr. Garcia on the Role of Navitoclax in Myelofibrosis

What patients benefit 0:02:24

What patients benefit most from the addition of venetoclax to FLAG-IDA?